v3.26.1
Stockholders' Equity (Deficit) - Additional Information (Detail) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 12, 2025
Jan. 16, 2025
Jan. 02, 2025
Dec. 23, 2024
Mar. 26, 2024
Aug. 09, 2023
Jul. 31, 2025
May 31, 2025
Apr. 30, 2024
Aug. 31, 2023
Jul. 31, 2023
Mar. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Oct. 11, 2024
Class of Stock [Line Items]                              
Common stock shares issued                         1,781,738 696,969  
Common stock shares authorized                         250,000,000 250,000,000  
Preferred stock shares authorized                         20,000,000    
Common stock, shares, outstanding                         1,781,738 696,969  
Gross proceeds from Issuance of common stock                         $ 3,483,790 $ 2,687,225  
Share based compensation                         692,790 $ 827,043  
Unrecognized compensation expense                         $ 1,177,542    
Estimated weighted average period over which expense is expected to be recognized                         2 years 1 month 20 days    
AxoBio [Member]                              
Class of Stock [Line Items]                              
Stock returned and retired                       128,178      
Series A Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Stock returned and retired         4,243                    
Preferred stock shares authorized                         4,243 4,243  
Series A Preferred Stock [Member] | Axolotl Acquisition [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period           4,243                  
2023 Long-Term Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Share-based compensation arrangement by share-based percentage award, award vesting rights, percentage                     25.00%        
Stock option, vesting period                     4 years        
2023 Long-Term Incentive Plan [Member] | Minimum [Member]                              
Class of Stock [Line Items]                              
Percentage of stock owned by individual                     10.00%        
Percentage of exercise price per share from fair market value                     110.00%        
2023 Incentive stock option [member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period                         34,880    
Share based compensation arrangement by share based payment award maximum stock issued description                         The initial maximum number of shares of Common Stock that may be issued under the 2023 Plan through incentive stock options was 34,880, which automatically increases on January 1 of each year for a period commencing on January 1, 2024, and ending on and including January 1, 2032, by an amount equal to the lesser of 50,000 shares, 4% of the outstanding shares of Common Stock determined on a fully diluted basis as of the immediately preceding year-end, or such smaller number of shares as determined by the Board or the compensation committee of the Board.    
2023 Incentive stock option [member] | Minimum [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period                     50,000        
Common Stock [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period                         748,461 44,382  
Warrants to purchase number of shares of common stock             298,000                
Proceeds from warrant exercise             $ 1,000,000                
Common Stock [Member] | Elevai Acquisition [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period                         38,308    
Number of shares issued at acquisition   38,308                     38,308    
Number of shares withheld at acquisition   3,927                     3,927    
Shares issued   $ 660,805                     $ 660,805    
Shares withheld   $ 67,742                     $ 67,742    
Common Stock [Member] | AxoBio [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period                   128,178          
Common Stock [Member] | Purchase Agreement [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period     268,840                        
Offering price     $ 6.9                        
Class of warrant or right, exercise price of warrants or rights $ 3.92                            
Common Stock Warrants [Member]                              
Class of Stock [Line Items]                              
Class of warrant or right, exercise price of warrants or rights                         $ 107.03 $ 303.3  
Common stock warrants outstanding                         447,673 154,744  
Common Stock Warrants [Member] | Purchase Agreement [Member]                              
Class of Stock [Line Items]                              
Warrants to purchase number of shares of common stock     268,840                        
Class of warrant or right, exercise price of warrants or rights     $ 6.9                        
Placement Agent [Member] | Common Stock [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period 473,220                            
Placement agent fees               $ 58,774              
Other offering expenses               $ 140,500              
2025 Private Placement [Member]                              
Class of Stock [Line Items]                              
Fair value of warrant     $ 311,000                        
Number of warrants issued 32,643                            
Placement agent fees       $ 186,699                      
Class of warrant or right, exercise price of warrants or rights $ 3.92                            
2025 Private Placement [Member] | Purchase Agreement [Member]                              
Class of Stock [Line Items]                              
Fair value of warrant $ 26,000                            
Placement agent fees     127,925                        
Other offering expenses     214,239                        
Class of warrant or right, exercise price of warrants or rights $ 3.92                            
Legal costs     60,000                        
2025 Private Placement [Member] | Common Stock [Member] | Purchase Agreement [Member]                              
Class of Stock [Line Items]                              
Gross proceeds from issuance of private placement     1,851,849                        
2025 Private Placement [Member] | Common Stock Warrants [Member] | Purchase Agreement [Member]                              
Class of Stock [Line Items]                              
Fair value of warrant     $ 311,000                        
Class of warrant or right, exercise price of warrants or rights     $ 6.9                        
Warrants and rights outstanding term     5 years                        
2025 Private Placement [Member] | Placement Agent [Member]                              
Class of Stock [Line Items]                              
Number of warrants issued 32,643                            
2025 Private Placement [Member] | Placement Agent [Member] | Common Stock Warrants [Member]                              
Class of Stock [Line Items]                              
Warrants to purchase number of shares of common stock     18,541                        
Warrants and rights outstanding term     5 years                        
ATM Financing [Member] | Common Stock Warrants and Placement Agent Warrants [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period 552,798                            
Fair value of warrant $ 6,000                            
Number of warrants issued 38,131                            
Class of warrant or right, exercise price of warrants or rights $ 3.36                            
ATM Financing [Member] | Common Stock [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period               479,621              
Gross proceeds from Issuance of common stock               $ 1,959,140              
ATM Financing [Member] | Common Stock [Member] | Maximum [Member]                              
Class of Stock [Line Items]                              
Offering price               $ 4.09              
ATM Financing [Member] | Common Stock [Member] | Minimum [Member]                              
Class of Stock [Line Items]                              
Offering price               3.36              
ATM Financing [Member] | Common Stock [Member] | Weighted Average [Member]                              
Class of Stock [Line Items]                              
Offering price               $ 4.08              
2024 Private Placement [Member]                              
Class of Stock [Line Items]                              
Common stock, shares issued during the period                 44,382            
Gross proceeds from issuance of private placement                 $ 3,000,950            
Placement agent fees                 212,212            
Legal costs                 39,276            
Private placement costs incurred                 313,725            
2024 Private Placement [Member] | Common Stock Warrants [Member]                              
Class of Stock [Line Items]                              
Fair value of warrant                 $ 129,495           $ 129,495
Class of warrant or right, exercise price of warrants or rights                 $ 84.38            
Warrants and rights outstanding term                 5 years            
Common stock warrants outstanding                 2,993